Literature DB >> 7295123

Simultaneous bilateral radiation for advanced bilateral retinoblastoma.

D H Abramson, R M Ellsworth, P Tretter, K Adams, F D Kitchin.   

Abstract

A retrospective review of 1,424 cases of retinoblastoma disclosed 34 patients with advanced bilateral retinoblastoma whose sole initial treatment was simultaneous bilateral radiation. All patients had a combination of bilateral group IV or V retinoblastoma. Mean age at diagnosis was 13.1 months. Five-year survival of patients was 88% (28/32). In two (7%) of 28 surviving patients, a second nonocular tumor developed: one inside and one outside the field of radiation. Of the 64 eyes treated, 44 ultimately were enucleated. Of ten eyes requiring a second course of radiation, nine were enucleated. In only one eye was enucleation due to radiation complications. Eleven patients required additional treatment with light coagulation, cryopexy, or cobalt plaques.

Entities:  

Mesh:

Year:  1981        PMID: 7295123     DOI: 10.1001/archopht.1981.03930020637003

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

Review 1.  Chemotherapy for retinoblastoma: a current topic.

Authors:  P T Finger; G Czechonska; H Demirci; A Rausen
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Pathological findings in enucleated eyes after intravitreal melphalan injection.

Authors:  Fariba Ghassemi; Fahimeh Asadi Amoli
Journal:  Int Ophthalmol       Date:  2013-09-17       Impact factor: 2.031

3.  Bilateral retinoblastoma: the prognosis for vision.

Authors:  C Migdal
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

4.  Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival.

Authors:  Jasmine H Francis; Ariana M Levin; Emily C Zabor; Y Pierre Gobin; David H Abramson
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

5.  Metastatic deaths in retinoblastoma patients treated with intraarterial chemotherapy (ophthalmic artery chemosurgery) worldwide.

Authors:  David H Abramson; Carol L Shields; Pascal Jabbour; Luiz Fernando Teixeira; José Roberto Falco Fonseca; Marcio Chaves Pedro Marques; Francis L Munier; Francesco Puccinelli; Theodora Hadjistilianou; Sandra Bracco; Guillermo Chantada; Alejandro Ceciliano; Y Pierre Gobin
Journal:  Int J Retina Vitreous       Date:  2017-10-23

6.  Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy.

Authors:  Jasmine H Francis; Nelli Roosipu; Ariana M Levin; Scott E Brodie; Ira J Dunkel; Y Pierre Gobin; David H Abramson
Journal:  Neoplasia       Date:  2018-06-22       Impact factor: 5.715

Review 7.  Treatment of Retinoblastoma: What Is the Latest and What Is the Future.

Authors:  Paula Schaiquevich; Jasmine H Francis; María Belén Cancela; Angel Montero Carcaboso; Guillermo L Chantada; David H Abramson
Journal:  Front Oncol       Date:  2022-04-01       Impact factor: 5.738

8.  Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.

Authors:  David H Abramson; Armida W M Fabius; Reda Issa; Jasmine H Francis; Brian P Marr; Ira J Dunkel; Y Pierre Gobin
Journal:  PLoS One       Date:  2015-12-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.